title: Intracranial stereotaxic cannulation for development of orthotopic glioblastoma allograft in Sprague-Dawley rats and histoimmunopathological characterization of the brain tumor.
abstract: Glioblastoma is the most common brain tumor that causes significant mortality annually. Limitations of the current therapeutic regimens warrant development of new techniques and treatment strategies in orthotopic animal model for better management of this devastating brain cancer. There are only a few experimental orthotopic models of glioblastoma for pre-clinical testing. In the present investigation, we successfully implanted rat C6 cells via intracranial stereotaxic cannulation in adult Sprague-Dawley rats for development and histoimmunopathological characterization of an advanced orthotopic glioblastoma allograft model, which could be useful for investigating the course of glioblastoma development as well as for testing efficacy of new therapeutic agents. The orthotopic glioblastoma allograft was generated by intracerebral injection of rat C6 cells through a guide-cannula system and after 21 post-inoculation days the brain tumor was characterized by histoimmunopathological experiments. Histological staining and immunofluorescent labelings for TERT, VEGF, Bcl-2, survivin, XIAP, and GFAP revealed the distinct characteristics of glioblastoma in C6 allograft, which could be useful as a target for treatment with emerging new therapeutic agents. Our investigation indicated the successful development of intracranial cannulated orthotopic glioblastoma allograft in adult Sprague-Dawley rats, making it as a useful animal model of glioblastoma for pre-clinical evaluation of various therapeutic strategies for the management of glioblastoma.
authors: Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA.
authors: Surajit
authors: S
authors: Karmakar
authors: M Foster
authors: MF
authors: Olive
authors: Naren L
authors: NL
authors: Banik
authors: Swapan K
authors: SK
authors: Ray
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor; D001932:Brain Neoplasms / Q000473:pathology*; D002404:Catheterization / Q000379:methods; D017690:Cell Transplantation / Q000295:instrumentation / Q000379:methods; D004396:Coloring Agents; D005455:Fluorescent Antibody Technique; D005909:Glioblastoma / Q000473:pathology*; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D009368:Neoplasm Transplantation / Q000295:instrumentation / Q000379:methods*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013238:Stereotaxic Techniques
chemical_list: D014408:Biomarkers, Tumor; D004396:Coloring Agents
references: Apoptosis. 2007 Apr;12 (4):671-84
references: 17219050
references: J Clin Neurosci. 2002 Nov;9(6):668-71
references: 12604281
references: Arch Pathol Lab Med. 2003 Jul;127(7):826-33
references: 12823036
references: Oncogene. 1998 Dec 24;17 (25):3247-59
references: 9916987
references: Neurosurgery. 2000 Oct;47(4):993-9; discussion 999-1000
references: 11014444
references: Neurosurgery. 1998 May;42(5):1083-99; discussion 1099-100
references: 9588554
references: Neurol Res. 2006 Jul;28(5):532-7
references: 16808885
references: Brain Res. 2004 May 1;1006(2):150-6
references: 15051518
references: Curr Cancer Drug Targets. 2006 Mar;6(2):147-80
references: 16529544
references: Neuroscience. 2006 Sep 1;141(3):1265-80
references: 16765523
references: Curr Opin Oncol. 1999 May;11(3):157-61
references: 10328588
references: Oncogene. 2004 Sep 30;23(45):7494-506
references: 15326475
references: Am J Clin Oncol. 2002 Feb;25(1):60-4
references: 11823699
references: Cancer Res. 2001 Dec 1;61(23):8569-77
references: 11731444
references: Childs Nerv Syst. 2006 Dec;22(12):1519-25
references: 17021732
references: Neurosci Lett. 2006 Oct 16;407(1):53-8
references: 16949208
references: J Neurochem. 2007 Jul;102(2):522-38
references: 17596214
references: J Neurooncol. 2005 Sep;74(3):225-32
references: 16187019
references: Cancer Lett. 1999 Jul 19;142(1):11-6
references: 10424775
references: J Neurovirol. 1999 Dec;5(6):538-55
references: 10602396
references: Neurosurgery. 2000 Oct;47(4):921-9; discussion 929-30
references: 11014432
references: J Neurochem. 2005 Jan;92(1):1-9
references: 15606891
references: Cancer. 2002 Aug 1;95(3):641-55
references: 12209758
references: Cancer. 2005 Jun 15;103(12):2606-15
references: 15880378
references: J Cereb Blood Flow Metab. 1997 Jul;17(7):713-31
references: 9270488
references: Lancet. 2002 Mar 23;359(9311):1011-8
references: 11937180
references: Br J Cancer. 2005 Feb 14;92(3):532-8
references: 15685240
references: BMC Cancer. 2006 Sep 23;6:226
references: 16995949
references: J Neurooncol. 2001 May;52(3):205-15
references: 11519850
references: Expert Opin Investig Drugs. 2003 Dec;12 (12 ):1899-924
references: 14640936
references: Neurosci Lett. 2007 Mar 30;415(3):242-7
references: 17335970
references: Cancer Res. 2004 Sep 15;64(18):6381-4
references: 15374943